P-4-33 NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia. A phase II clinical trial

✍ Scribed by J. Karle; J. Gerlach; L. Clemmesen; L. Hansen; M. Andersen; J. Andersen; C. Fensbo; H. Lublin; M. Sloth-Nielsen; B. Skrumsager

• Book ID: 119176259
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 140 KB
• Volume: 5
• Category: Article
• ISSN: 0924-977X
• DOI: 10.1016/0924-977x(95)90553-p